nach oben

Current Cardiovascular Imaging Reports

Erschienen in:

01.05.2014 | Cardiac Nuclear Imaging (A Cuocolo, Section Editor)

Risk Stratification with Cardiac Rubidium-82 Positron Emission Tomography

verfasst von: Thomas F. Boyden, Venkatesh L. Murthy

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Positron emission tomography (PET) is an increasingly used imaging modality for stress myocardial perfusion imaging (MPI). Over the last several years, a rapidly increasing body of work supporting its use for estimation of extent and severity of coronary artery disease (CAD) and prognostication of risk of adverse cardiac events. In this review, we summarize these data, highlighting the strengths of PET MPI compared to single photon emission computed tomography (SPECT) with an emphasis on the differences in image acquisition, the ability to evaluate left ventricular systolic function during peak stress and the quantification of myocardial blood flow and coronary flow reserve.

Ghotbi AA, Kjaer A, Hasbak P. Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging. Clin Physiol Funct Imaging. 2013. doi:10.1111/cpf.12083.PubMed

Caobelli F, Farina D, Pizzocaro C, Guerra UP. Will the new advantages provided by PET in myocardial perfusion imaging help nuclear cardiology survive the test of time against conventional radiological techniques? Eur J Nucl Med Mol Imaging. 2012;39:1970–2.PubMedCrossRef

Nakazato R, Berman DS, Alexanderson E, Slomka P. Myocardial perfusion imaging with PET. Imaging Med. 2013;5:35–46.PubMedCentralPubMedCrossRef

Renaud JM, Mylonas I, McArdle B, Dowsley T, Yip K, Turcotte E, et al. Clinical interpretation standards and quality assurance for the multicenter PET/CT trial: 82Rb as an alternative radiopharmaceutical for myocardial imaging. J Nucl Med Off Publ Soc Nucl Med. 2013. doi:10.2967/jnumed.112.117515.

Rahmim A, Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun. 2008;29:193–207.PubMedCrossRef

Lewellen TK, Time-of-flight PET. Semin Nucl Med. 1998;28:268–75.PubMedCrossRef

Heinrich J. Prescription drugs: many factors affected Fda’s approval of selected “Pipeline” drugs [Internet]. Washington, D.C.: United States General Accounting Office; 2000 [cited 2014 Jan 12]. Available from: http://www.gao.gov/archive/2000/he00140.pdf.

Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol. 2005;14:71–8.PubMedCrossRef

Sharir T, Bacher-Stier C, Dhar S, Lewin HC, Miranda R, Friedman JD, et al. Identification of severe and extensive coronary artery disease by postexercise regional wall motion abnormalities in Tc-99m sestamibi gated single-photon emission computed tomography. Am J Cardiol. 2000;86:1171–5.PubMedCrossRef

10.

Ficaro EP, Fessler JA, Shreve PD, Kritzman JN, Rose PA, Corbett JR. Simultaneous transmission/emission myocardial perfusion tomography. Diagnostic accuracy of attenuation-corrected 99mTc-sestamibi single-photon emission computed tomography. Circulation. 1996;93:463–73.PubMedCrossRef

11.•

Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60:1828–37. This meta-analysis of 15 PET and 8 SPECT studies (1344 and 1755 patients, respectively) compared the sensitivity and specificity of PET vs. SPECT.PubMedCrossRef

12.•

Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging. 2012;5:700–7. This meta-analysis of 4 PET and 108 SPECT studies (11,862 patients) compared the sensitivity, specificity and diagnostic accuracy of PET vs. SPECT concluding that PET has a higher sensitivity compared to SPECT.PubMedCrossRef

13.

Yoshinaga K, Chow BJW, Williams K, Chen L, deKemp RA, Garrard L, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006;48:1029–39.PubMedCrossRef

14.

Dorbala S, Hachamovitch R, Curillova Z, Thomas D, Vangala D, Kwong RY, et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009;2:846–54.PubMedCentralPubMedCrossRef

15.•

Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J Am Coll Cardiol. 2013;61:176–84. This multi-center study evaluated the prognostic value of stress PET MPI in 7061 patients from four centers.PubMedCentralPubMedCrossRef

16.

Dorbala S, Vangala D, Sampson U, Limaye A, Kwong R, Di Carli MF. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. J Nucl Med Off Publ Soc Nucl Med. 2007;48:349–58.

17.

Porenta G, Cherry S, Czernin J, Brunken R, Kuhle W, Hashimoto T, et al. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med. 1999;26:1465–574.PubMedCrossRef

18.•

Murthy VL, Di Carli MF. Non-invasive quantification of coronary vascular dysfunction for diagnosis and management of coronary artery disease. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2012;19:1060–72. This review summarizes current knowledge regarding the use of coronary flow reserve using PET.CrossRef

19.•

Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215–24. This analysis of 2783 patients demonstrates that CFR is a powerful and independent predictor of cardiac death for patients with known or suspected coronary artery disease. Additionally, CFR offers incremental risk reclassification over clinical and gated MPI variables.PubMedCentralPubMedCrossRef

20.•

Farhad H, Dunet V, Bachelard K, Allenbach G, Kaufmann PA, Prior JO. Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging. Eur Heart J Cardiovasc Imaging. 2013;14:1203–10. This analysis of 351 patients with PET MPI demonstrates that stress myocardial blood flow may be as powerful as a predictor of clinical risk assessment as CFR and can provide incremental data for risk stratification.PubMedCrossRef

21.

Fukushima K, Javadi MS, Higuchi T, Lautamäki R, Merrill J, Nekolla SG, et al. Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. J Nucl Med Off Publ Soc Nucl Med. 2011;52:726–32.

22.

Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography: added value of coronary flow reserve. J Am Coll Cardiol. 2009;54:150–6.PubMedCrossRef

23.

Tio RA, Dabeshlim A, Siebelink H-MJ, de Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med. 2009;50:214–9.PubMedCrossRef

24.•

Ziadi MC, deKemp RA, Williams KA, Guo A, Chow BJW, Renaud JM, et al. Impaired myocardial flow reserve on Rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740–8. This prospective analysis of 704 patients evaluated with PET MPI demonstrates that abnormal CFR is associated with an increased risk of major adverse cardiac events.PubMedCrossRef

25.

Naya M, Murthy VL, Blankstein R, Sitek A, Hainer J, Foster C, et al. Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. J Am Coll Cardiol. 2011;58:1807–16.PubMedCentralPubMedCrossRef

26.•

Naya M, Murthy VL, Foster CR, Gaber M, Klein J, Hainer J, et al. Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease. J Am Coll Cardiol. 2013;61:2098–106. This analysis of 901 patients with normal stress perfusion demonstrates the PET MPI with CFR provides superior incremental risk stratification over clinical risk score for prediction of MACE compared to coronary artery calcium.PubMedCrossRef

27.•

Naya M, Murthy VL, Taqueti VR, Foster CR, Klein J, Garber M, et al. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med Off Publ Soc Nucl Med. 2014. doi:10.2967/jnumed.113.121442. This analysis of 290 patients who underwent 82Rb-PET MPI within 180 days of invasive coronary angiography demonstrates that a normal CFR has an excellent negative predictive value for high risk coronary disease (three-vessel/left main CAD). An abnormal CFR cannot distinguish epicardial from non-obstructive, diffuse atherosclerosis.

28.•

Ziadi MC, Dekemp RA, Williams K, Guo A, Renaud JM, Chow BJW, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2012;19:670–80. This prospective study of 120 patients with stress PET MPI and coronary angiography within six months demonstrates that diminished CFR is an independent predictor of three-vessel CAD.CrossRef

29.

Lertsburapa K, Ahlberg AW, Bateman TM, Katten D, Volker L, Cullom SJ, et al. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2008;15:745–53.CrossRef

30.•

Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126:1858–68. This analysis of 2,783 patients demonstrates that coronary vascular dysfunction is a powerful predictor of cardiac mortality. This relationship holds for both diabetics and non-diabetics, and demonstrates that for diabetics without CAD, abnormal CFR implies a level of risk similar to that of patients with CAD.PubMedCentralPubMedCrossRef

31.

Furuhashi T, Moroi M, Joki N, Hase H, Masai H, Kunimasa T, et al. The impact of chronic kidney disease as a predictor of major cardiac events in patients with no evidence of coronary artery disease. J Cardiol. 2010;55:328–36.PubMedCrossRef

32.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.PubMedCrossRef

33.

Meisinger C, Döring A, Löwel H, KORA Study Group. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J. 2006;27:1245–50.PubMedCrossRef

34.

Nakanishi K, Fukuda S, Shimada K, Miyazaki C, Otsuka K, Kawarabayashi T, et al. Prognostic value of coronary flow reserve on long-term cardiovascular outcomes in patients with chronic kidney disease. Am J Cardiol. 2013;112:928–32.PubMedCrossRef

35.

Charytan DM, Shelbert HR, Di Carli MF. Coronary microvascular function in early chronic kidney disease. Circ Cardiovasc Imaging. 2010;3:663–71.PubMedCrossRef

36.

Al-Mallah MH, Hachamovitch R, Dorbala S, Di Carli MF. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction. Circ Cardiovasc Imaging. 2009;2:429–36.PubMedCrossRef

37.

Furuhashi T, Moroi M, Joki N, Hase H, Masai H, Kunimasa T, et al. The predictive value of chronic kidney disease for assessing cardiovascular events under consideration of pretest probability for coronary artery disease in patients who underwent stress myocardial perfusion imaging. Int J Cardiovasc Imaging. 2013;29:513–9.PubMedCrossRef

38.

Fukushima K, Javadi MS, Higuchi T, Bravo PE, Chien D, Lautamäki R, et al. Impaired global myocardial flow dynamics despite normal left ventricular function and regional perfusion in chronic kidney disease: a quantitative analysis of clinical 82Rb PET/CT studies. J Nucl Med Off Publ Soc Nucl Med. 2012;53:887–93.

39.•

Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Dorbala S, et al. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012;5:1025–34. This analysis of 866 patients with moderate to severe renal disease demonstrates that impaired CFR in patients with CKD is a powerful predictor of cardiac mortality. The inclusion of CFR provides incremental risk stratification to conventional markers of cardiovascular risk.PubMedCentralPubMedCrossRef

40.

Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention. American Heart Association. Circulation. 2005;111:682–96.PubMedCrossRef

41.

Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2004;11:551–61.CrossRef

42.

Shaw LJ, Miller DD, Romeis JC, Kargl D, Younis LT, Chaitman BR. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med. 1994;120:559–66.PubMedCrossRef

43.

Iskandar A, Limone B, Parker MW, Perugini A, Kim H, Jones C, et al. Gender differences in the diagnostic accuracy of SPECT myocardial perfusion imaging: a bivariate meta-analysis. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2013;20:53–63.CrossRef

44.

Shawgi M, Tonge CM, Lawson RS, Muthu S, James J, Arumugam P. Attenuation correction of myocardial perfusion SPET in patients of normal body mass index. Hell J Nucl Med. 2012;15:215–9.PubMed

45.

Rivero A, Santana C, Folks RD, Esteves F, Verdes L, Esiashvili S, et al. Attenuation correction reveals gender-related differences in the normal values of transient ischemic dilation index in rest-exercise stress sestamibi myocardial perfusion imaging. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2006;13:338–44.CrossRef

46.

Wu Y-T, Chien C-L, Wang S-Y, Yang W-S, Wu Y-W. Gender differences in myocardial perfusion defect in asymptomatic postmenopausal women and men with and without diabetes mellitus. J Womens Health 2002. 2013;22:439–44.CrossRef

47.•

Kay J, Dorbala S, Goyal A, Fazel R, Di Carli MF, Einstein AJ, et al. Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry. J Am Coll Cardiol. 2013;62:1866–76. This analysis of 6,037 patients from multiple centers demonstrates that 82Rb-PET provides meaningful and significant risk stratification for both women and men. This modality was particulary useful at identifiying high-risk, older women.PubMedCrossRef

48.

Ziadi MC, Dekemp RA, Yoshinaga K, Beanlands RS. Chapter 19—diagnosis and prognosis in cardiac disease using cardiac PET perfusion imaging. In: Zaret BL, Beller GA, editors. Clin Nucl Cardiol State Art Future Dir. [Internet]. Fourth Edition. Philadelphia: Mosby; 2010 [cited 2014 Jan 21]. p. 309–31. Available from: http://www.sciencedirect.com/science/article/pii/B9780323057967000370.

49.

Hsu B. PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease. J Biomed Res. 2013;27:452–9.PubMedCentralPubMedCrossRef

50.

Machac J. Radiopharmaceuticals for clinical cardiac PET imaging. In: Di Carli MF, Lipton MJ, editors. Card. PET PETCT Imaging [Internet]. Springer New York; 2007 [cited 2014 Jan 21]. p. 73–82. Available from: http://link.springer.com/chapter/10.1007/978-0-387-38295-1_5.

Titel: Risk Stratification with Cardiac Rubidium-82 Positron Emission Tomography
verfasst von: Thomas F. Boyden
Venkatesh L. Murthy
Publikationsdatum: 01.05.2014
Verlag: Springer US
Erschienen in: Current Cardiovascular Imaging Reports / Ausgabe 5/2014
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI: https://doi.org/10.1007/s12410-014-9266-0

Neu im Fachgebiet Kardiologie

23.04.2024 | Ablationstherapie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Risk Stratification with Cardiac Rubidium-82 Positron Emission Tomography

Abstract

Neu im Fachgebiet Kardiologie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Improved Prediction of Major Cardiac Events by Gated Myocardial Perfusion Imaging

Cardiac Stem Cell Imaging by SPECT and PET

Cardiovascular Magnetic Resonance Imaging of Myocardial Interstitial Expansion in Hypertrophic Cardiomyopathy

The Use of Superparamagnetic Iron Oxide Nanoparticles to Assess Cardiac Inflammation

Neu im Fachgebiet Kardiologie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Kardiologie